{"transactions":[{"id":692504,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-10T14:18:44.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter."}],"balance_after":343750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001193125-26-341528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526341528/ownership.xml","form_type":"4"}},{"id":692503,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-10T14:18:44.000Z","date":"2026-08-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":8888,"price":0.5,"value":4444.0,"ownership":{"direct":true},"balance_after":170901,"source":{"system":"sec-edgar","filing":"0001193125-26-341528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526341528/ownership.xml","form_type":"4"}},{"id":692502,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-10T14:18:44.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":179789,"source":{"system":"sec-edgar","filing":"0001193125-26-341528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526341528/ownership.xml","form_type":"4"}},{"id":699418,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T15:20:56.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":false,"shares":11769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":164776,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11769},"source":{"system":"sec-edgar","filing":"0001193125-26-329848","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329848/ownership.xml","form_type":"4"}},{"id":699417,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-03T15:20:56.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":true,"shares":11769,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":148539,"source":{"system":"sec-edgar","filing":"0001193125-26-329848","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329848/ownership.xml","form_type":"4"}},{"id":789138,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-07T17:01:10.000Z","date":"2026-05-06","kind":"exercise","planned":false,"acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter."}],"balance_after":375000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001193125-26-211230","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526211230/ownership.xml","form_type":"4"}},{"id":789137,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-07T17:01:10.000Z","date":"2026-05-06","kind":"exercise","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":136770,"source":{"system":"sec-edgar","filing":"0001193125-26-211230","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526211230/ownership.xml","form_type":"4"}},{"id":794661,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T16:49:09.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":11770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":176545,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11770},"source":{"system":"sec-edgar","filing":"0001193125-26-203374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203374/ownership.xml","form_type":"4"}},{"id":794660,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-04T16:49:09.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11770,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":11770,"source":{"system":"sec-edgar","filing":"0001193125-26-203374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203374/ownership.xml","form_type":"4"}},{"id":923405,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T15:00:03.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":188314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Performance stock units (\"PSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 188,314 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 188,314 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."}],"balance_after":188314,"derivative":{"underlying":"Common Stock","underlying_shares":188314},"source":{"system":"sec-edgar","filing":"0001193125-26-034625","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034625/ownership.xml","form_type":"4"}},{"id":923404,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T15:00:03.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":188315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."}],"balance_after":188315,"derivative":{"underlying":"Common Stock","underlying_shares":188315},"source":{"system":"sec-edgar","filing":"0001193125-26-034625","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034625/ownership.xml","form_type":"4"}},{"id":1156826,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-07T16:20:50.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installmens thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installmens thereafter."}],"balance_after":500000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000950170-25-065310","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025065310/ownership.xml","form_type":"4"}}]}